Fisher & Paykel Healthcare | FPH - Ebit

Aktienkurs
29.26
Täglich Wechseln
-0.16 -0.54%
Monatlich
-2.82%
Jährlich
-8.53%
Q2 Prognose
28.86




Ebit Veränderung Datum
Cochlear AUD 261.1M 13.9M 2025-12
CSL USD 2.64B 116M 2025-12
Nanosonics AUD 9.12M 422K 2025-12
Ramsay Health Care AUD 541.1M 20.7M 2025-12
ResMed USD 497.6M 35.25M 2025-12
Somnomed AUD -1.99M 83.11K 2023-06
Sonic Healthcare AUD 423.94M 80.3M 2024-12